function
channel
protein
essenti
releas
flu
viru
genet
materi
insid
infect
cell
channel
protein
phsensit
proton
channel
also
play
key
role
viru
replic
regul
viru
morpholog
two
adamantan
derivativebas
drug
amantadin
rimantadin
figur
use
firstchoic
antivir
drug
commun
outbreak
first
antivir
licens
effect
influenza
virus
howev
sinc
frequenc
amantadin
resist
increas
significantli
less
greater
isol
influenza
viru
therefor
great
urgent
need
discov
new
type
inhibitor
develop
new
drug
due
new
mutat
channel
protein
drugresist
amantadin
rimantadin
new
drug
direct
channel
protein
univers
effect
previou
one
amantadin
rimantadin
becom
resist
influenza
viru
recent
sitedirect
mutagenesi
molecular
dynam
simul
carri
investig
amantadin
resist
transmembran
domain
channel
protein
accord
statist
data
resist
mutant
substitut
occur
posit
around
occur
posit
vitro
clinic
sampl
solv
drugresist
problem
reliabl
molecular
structur
channel
protein
high
prioriti
design
new
drug
channel
protein
structur
obtain
experiment
previou
studi
thu
becom
main
target
scientist
pharmacologist
find
drug
influenza
viru
use
structurebas
drug
design
approach
one
highresolut
nuclear
magnet
reson
nmr
spectroscopi
structur
schnell
chou
protein
data
bank
pdb
code
entri
success
provid
fulllength
structur
channel
protein
channel
protein
built
sequenc
genbank
access
number
also
use
current
research
previou
studi
drug
bind
affin
modifi
function
group
amantadin
reveal
detail
ligand
actual
bind
molecular
level
research
aim
search
drug
candid
effect
resist
strain
influenza
virus
shed
light
sever
import
insight
top
hit
proteininhibitor
interact
studi
drug
candid
design
modifi
ad
function
group
amantadin
scaffold
use
virtual
screen
process
top
bind
compound
select
studi
pharmacophor
analysi
two
possibl
bind
site
channel
protein
influenza
found
experiment
studi
drug
bind
locat
molecular
dock
result
amantadin
rimantadin
posit
insid
outsid
channel
protein
partial
support
actual
bind
site
locat
free
energi
bind
amantadin
rimantadin
insid
channel
gener
lower
bind
outsid
channel
protein
cf
tabl
compar
two
case
affin
insid
channel
bind
higher
outsid
channel
ligand
bind
insid
channel
protein
bind
hydrogen
bond
cf
figur
format
hydrogen
bond
channel
protein
observ
either
amantadin
rimantadin
meanwhil
outsid
channel
bind
ligand
channel
protein
larg
unchang
term
free
bind
energi
locat
bind
site
indic
bind
ligand
protein
structur
energet
favour
stabl
ligand
either
amantadin
rimantadin
insid
channel
outsid
channel
protein
sinc
exact
locat
function
adamantin
bind
site
sourc
controversi
better
design
novel
inhibitor
comparison
analysi
two
bind
posit
taken
consider
studi
compound
divid
group
base
structur
similar
free
energi
bind
compound
channel
protein
two
posit
name
insid
outsid
channel
shown
tabl
select
top
bind
compound
mostli
base
choos
common
compound
posit
lowest
free
energi
bind
channel
protein
comparison
amantadin
rimantadin
top
compound
rank
base
lowest
free
energi
bind
obtain
dock
indic
better
bind
affin
two
group
select
lowest
energi
bind
virtual
screen
insid
outsid
channel
protein
respect
tabl
show
affin
drug
candid
bind
insid
channel
much
higher
bind
outsid
channel
protein
group
insid
channel
gener
bind
high
affin
hydrophob
interact
insid
channel
protein
hydrophob
residu
particular
compound
high
possibl
form
hydrogen
bond
predict
amino
group
two
residu
wherea
methyl
group
interact
hydrophob
part
channel
protein
subsequ
high
affin
select
pharmacophor
analysi
top
hit
proteininhibitor
interact
besid
group
bind
outsid
channel
basic
bind
lower
affin
hydrogen
bond
everi
compound
either
protein
type
hydrophob
interact
interestingli
compound
ident
respect
cf
tabl
therefor
two
compound
select
top
hit
either
insid
outsid
bind
channel
protein
pharmacophor
analysi
specif
drug
targetprotein
interact
moreov
free
energi
bind
top
compound
bind
insid
outsid
channel
protein
compar
detail
cf
figur
ligandscout
present
interact
channel
protein
ligand
well
exclud
volum
sphere
correspond
complex
structur
term
potenti
drugtarget
bind
studi
top
two
select
hit
compound
visual
clearli
possibl
interact
critic
residu
channel
protein
gener
four
pharmacophor
model
two
highli
potent
bind
compound
insid
outsid
channel
protein
geometr
constraint
activ
site
repres
tabl
shown
tabl
insid
channel
protein
complex
gener
pharmacophor
contain
one
hydrophob
h
chemic
featur
point
toward
four
featur
hypothesi
gener
insid
channel
complex
compris
one
hba
toward
three
h
group
mostli
orient
toward
exclud
volum
sphere
five
featur
hypothesi
gener
outsid
channel
complex
includ
one
hba
toward
four
h
group
point
toward
exclud
volum
sphere
outsid
channel
complex
produc
four
featur
hypothesi
consist
one
hba
three
h
group
nine
exclud
volum
sphere
hba
group
point
toward
h
group
point
toward
respect
compar
four
pharmacophor
model
hba
h
group
model
point
toward
insid
channel
protein
arg
outsid
channel
play
major
role
inhibit
channel
protein
activ
respect
result
suggest
residu
extrem
import
bind
site
novel
channel
inhibitor
best
hypothesi
hiphop
chosen
seventeen
hypothes
insid
group
eighteen
hypothes
outsid
group
use
common
featur
pharmacophor
generationdiscoveri
studio
result
two
repres
pharmacophor
featur
top
insid
bind
outsid
bind
compound
identifi
cf
figur
group
compound
bind
insid
channel
protein
gener
pharmacophor
contain
one
hba
three
h
chemic
featur
similarli
three
featur
hypothesi
gener
group
outsid
bind
compound
compos
one
hba
two
h
group
henc
hba
h
featur
consid
import
chemic
featur
discov
novel
channel
inhibitor
consist
predict
ligandscout
common
featur
discoveri
studio
also
indic
top
bind
compound
either
insid
outsid
fit
common
featur
pharmacophor
function
group
interact
critic
residu
channel
protein
templat
model
construct
highresolut
nmr
structur
channel
protein
pdb
code
model
construct
viru
protein
sequenc
taken
genbank
access
number
isol
juli
viru
strain
japan
cf
figur
synthet
inhibitor
channel
protein
amantadin
scaffold
base
adamantan
deriv
select
publish
work
gayday
et
al
du
et
al
eleftherato
et
al
papanastasi
et
al
tanner
et
al
de
clercq
tataridi
et
al
stamati
et
al
balannik
et
al
other
newli
creat
ligand
investig
dock
channel
protein
either
insid
outsid
posit
design
principl
potenti
target
drugresist
influenza
mutant
aim
introduc
addit
function
group
aamantadin
scaffold
includ
ad
amin
hydroxyl
linear
cyclohexan
aromat
benzen
group
order
increas
bind
affin
inhibitor
amino
group
amantadin
like
pharmacophor
necessari
block
hydrogen
ion
transport
consequ
scaffold
base
adamantyl
group
select
suitabl
function
group
attach
scaffold
form
new
compound
potenti
bind
well
channel
protein
key
residu
bind
site
prior
molecular
dock
simul
new
potenti
inhibitor
built
use
gaussview
softwar
compound
optim
geometr
use
discoveri
studio
visual
molecular
dock
simul
two
type
channel
protein
repres
viru
strain
use
receptor
two
differ
dock
posit
insid
outsid
channel
autodock
tool
version
use
add
polar
hydrogen
assign
kollman
charg
creat
grid
bind
box
volum
grid
box
default
space
type
channel
protein
structur
autogrid
version
use
creat
grid
center
activ
site
base
coexist
two
possibl
bind
posit
two
exist
channel
protein
dock
inhibitor
channel
separ
four
categori
dock
insid
channel
protein
dock
insid
channel
protein
dock
outsid
channel
protein
dock
outsid
channel
protein
posit
control
dock
obtain
redock
amantadin
rimantadin
extract
nmr
structur
locat
bind
site
channel
protein
dock
ligand
bind
box
insid
channel
protein
posit
encompass
three
possibl
bind
site
name
bind
box
outsid
channel
protein
set
cover
two
import
function
residu
channel
gate
channel
lock
bind
affin
calcul
autogrid
version
use
follow
atom
type
aromat
carbon
carbon
c
fluorin
f
iodin
nitrogen
n
hydrogen
bond
accept
n
na
oxygen
hydrogen
bond
accept
oa
sulfur
hydrogen
bond
accept
sa
silicon
si
hydrogen
h
electrostat
e
ligand
set
includ
new
inhibitor
creat
previous
publish
studi
other
newli
creat
modifi
ad
function
group
adamantan
scaffold
autodocktool
also
use
merg
nonpolar
hydrogen
add
charg
visual
set
rotat
bond
ligand
via
autotor
lamarckian
genet
algorithm
use
perform
dock
experi
autodock
paramet
optim
follow
trial
dock
popul
size
random
start
posit
conform
translat
step
rang
rotat
step
rang
degre
maximum
number
gener
elit
mutat
rate
crossov
rate
local
search
rate
energi
evalu
dock
conform
cluster
toler
rmsd
dock
result
sort
lowest
bind
energi
popul
cluster
use
autodocktool
version
top
hit
group
bind
insid
outsid
channel
protein
select
analysi
top
ten
compound
bind
insid
outsid
channel
protein
lowest
bind
energi
use
gener
structurebas
pharmacophor
model
channelinhibitor
observ
verifi
compar
interact
bind
insid
outsid
channel
protein
ligand
interact
critic
amino
acid
present
activ
site
channel
protein
pharmacophor
base
best
result
virtual
screen
provid
suffici
input
gener
structurebas
ligandscout
use
studi
interact
inhibitor
amino
acid
two
bind
site
channel
well
tool
automat
construct
visual
structur
base
pharmacophor
model
ligandscout
extract
interpret
ligandreceptor
interact
hydrogen
bond
charg
transfer
hydrophob
region
macromolecular
environ
chemic
featur
includ
hydrogenbond
donor
acceptor
direct
vector
posit
neg
ioniz
area
well
lipophil
area
repres
sphere
order
increas
select
exclud
volum
sphere
ad
reflect
potenti
steric
restrict
coordin
interact
obtain
result
interact
model
abl
map
ligand
bioactiv
conform
result
top
compound
bind
side
import
insid
interact
hold
stabil
drug
insid
channel
protein
select
visualis
identif
import
common
chemic
featur
top
bind
compound
insid
outsid
channel
protein
help
discov
potent
candid
inhibit
viru
strain
pharmacophor
model
mostli
depend
qualiti
molecul
structur
use
gener
pharmacophor
conform
work
train
set
molecul
select
two
differ
group
top
compound
bind
insid
channel
protein
top
compound
bind
outsid
channel
protein
bond
order
inhibitor
check
verifi
gener
pharmacophor
model
conform
flexibl
select
ligand
accomod
creat
multipl
conform
cover
repres
specifi
energi
threshold
hiphop
modul
discoveri
studio
softwar
employ
build
plausibl
bind
hypothesi
identifi
set
chemic
featur
common
potent
train
molecul
structur
gener
chemic
featur
consid
train
set
hydrogen
bond
donor
acceptor
hbd
hba
aliphat
hydrophob
eighteen
hypothes
gener
outsid
group
seventeen
hypothes
creat
insid
group
best
hypothesi
group
select
base
high
number
compound
fit
well
high
fit
valu
hypothesi
studi
top
highli
potent
compound
among
new
compound
base
amantadin
scaffold
identifi
combin
differ
comput
methodolog
result
also
confirm
bind
insid
posit
favour
stabl
bind
outsid
channel
protein
result
obtain
base
virtual
screen
reveal
top
compound
bind
posit
insid
outsid
channel
higher
bind
affin
channel
protein
amantadin
rimantadin
detail
pharmacophor
analysi
top
hit
among
channel
inhibitor
also
reveal
natur
interact
function
group
top
bind
candid
channel
protein
studi
two
compound
predict
activ
inhibitor
viru
strain
howev
due
limit
method
employ
find
addit
mutat
channel
protein
studi
would
requir
accur
calcul
confirm
molecular
dynam
simul
done
futur
captur
flexibl
interact
channel
protein
togeth
vitro
vivo
studi
top
bind
compound
